PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
24.37%
Similar revenue growth to CRWV's 23.55%. Walter Schloss would investigate if similar growth reflects similar quality.
50.60%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
21.34%
Similar gross profit growth to CRWV's 25.15%. Walter Schloss would investigate industry dynamics.
-2.44%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
14.39%
R&D change of 14.39% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.55%
Similar operating expenses growth to CRWV's 17.97%. Walter Schloss would investigate norms.
20.11%
Total costs growth 1.1-1.25x CRWV's 18.28%. Bill Ackman would demand justification.
No Data
No Data available this quarter, please select a different quarter.
4.55%
D&A growth less than half of CRWV's 26.15%. David Dodd would verify if efficiency is sustainable.
29.93%
Similar EBITDA growth to CRWV's 33.05%. Walter Schloss would investigate industry trends.
-1.39%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
33.08%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
7.01%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
313.33%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
40.77%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
13.19%
Pre-tax margin growth below 50% of CRWV's 26.86%. Michael Burry would check for structural issues.
51.40%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
35.60%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
9.03%
Net margin growth below 50% of CRWV's 25.27%. Michael Burry would check for structural issues.
42.86%
EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
42.86%
Diluted EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
-5.29%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-5.29%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.